Neuroscience is an interdisciplinary field that includes language, computation, philosophy, psychology, and chemistry. Neuroscience studies the neurotic system's cellular, operational, behavioral, molecular, evolutionary, and therapeutic components. There are several approaches for imaging the nervous system in the discipline of neuroscience. Neuroscience, as the study of the nervous system, is concerned with analyzing and visualizing how the human brain functions. The growth of partnerships between major industry giants and startups for the development of neuroscience-based technologies is expected to boost the global neuroscience market. The market is anticipated to expand as a result of increased drug discovery research effort.
The global Neuroscience market is anticipated to expand at a CAGR of 4.1% from 2023 to 2030.
Market Players in the Neuroscience Industry:
1. Alpha Omega, Inc.
Alpha Omega, Inc. was founded in 1993 and headquartered in HaZafon, Israel. It operates around the world, in Israel headquarters, USA, Germany, and China. In August 2022, Aster Medcity, in collaboration with Medtronic, introduces NeuroNav MER System Alpha Omega for Deep Brain Stimulation DBS therapy used for Parkinson's disease patients for the first time in South Asia.
2. GE Healthcare
GE Healthcare was founded in 1994 and headquartered in Illinois, United States. It operates in more than 100 countries. In April 2022, GE Healthcare and Imeka will collaborate to provide researchers and physicians with highly localized views of white matter, which can provide vital insights into the impact of central nervous system diseases and disorders.GE Healthcare and Imeka aspire to improve precision medicine for brain health by expanding the capabilities of MRI for brain imaging.
3. Axion Biosystems, Inc.
Axion Biosystems, Inc. was founded in 2007 and headquartered in Atlanta, Georgia. It operates 12 countries and around the world. In January 2023, Axion BioSystems unveiled the Omni Pro 12 high-throughput live-cell imaging system. Axion BioSystems has expanded its Omni live-cell imaging product line with the addition of the Omni Pro 12. The new platform gives researchers and drug developers more flexibility and efficiency when conducting live-cell imaging experiments since it integrates robotics and has a multiplate design that is compatible with any standard incubator.